Hello and welcome, please come in and join us for episode 60 of Calling Peston, the ITV News Politics Podcast, twice nominated for podcast of the year, and as far as I'm aware, twice defeated. I'm Daniel Hewitt. That is Sheehab Khan.

Hello. And that is Robert Peston.

Hello.

Love it to speak to you.

And when you say twice defeated, nonetheless, we always play a good game, don't we?

The fans are with us.

It's the taking part of the accounts.

And today we're going to get straight into our chat with Robert because he has some potentially really big news.

Robert, you're hearing some positive news about the COVID vaccine being trialled at Oxford University.

Please do tell us more.

That's right.

So earlier today, what I discovered is they're about to put out some important data about trials that have been taking place.

They'll be in the Lancet.

And as I understand it, what the researchers are finding is about as positive as they could hope when it comes to the generation of antibodies, but also the stimulation of what are known as

T-cells. Now, T-cells are vital part of the of antibodies, but also the stimulation of what are known as T cells.

Now, T cells are vital part of the immune system.

There's been quite a lot of research recently showing that T cells can play really quite

a positive role, some scientists think, in protecting us from coronavirus.

And I'm hoping you're not going to drill down any further into my knowledge of T cells because I think we've exhausted, but I broadly know, except to say that as I understand it, what this vaccine does in terms of stimulating the activity of T cells

is regarded as very positive. And the other thing about this vaccine, which I think is making

some people excited, is there are some sort of vaccines that concentrate only on stimulating

antibodies or others that play a role with T-cells,

...